AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $183.0M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 27/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 78.0¢ | Day High | 80.3¢ | Day Low | 78.0¢ | |||
| Daily Volume | 857587 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 79.0¢ | 21241 | 0 | 80.5¢ | 65850 | |
Directors & Senior Management
| Mr. Adam Thomas | Chief Technology Officer |
| Mr. Adrian Wong | Chief Legal Officer & Company Secretary |
| Mr. Axel Freytag | Chief Commercial Officer of B2C |
| Ms. Catherine Louise Kovacs | Non-Executive Independent Director |
| Ms. Constance Bernadette Carnabuci | Non-Executive Independent Director |
| Ms. Jacqueline Cherie Hey | Independent Non-Executive Director |
| Mr. James Gladstone Georgeson | Chief Financial Officer |
| Mr. John Alexander Malcolm | CEO, MD & Executive Director |
| Mr. Joshua Goines | Chief Growth Officer |
| Ms. Kate Malone | Chief Risk Officer |
| Ms. Kate Svoboda | Chief People & Culture Officer |
| Ms. Maeve McMahon | Chief Commercial Officer of B2B |
| Mr. Matthew Gregorowski | Investor Relations |
| Ms. Patricia Anne Cross | Independent Non-Executive Chair |
| Ms. Rebecca Blair | Company Secretary |
| Mr. Robert Bazzani | Independent Non-Executive Director |
| Mr. Yung Ngo | Chief Customer Officer |
Data source: ADVFN
